Intranasal delivery of pGDNF nanoparticles for Parkinson's disease
Parkinson's disease (PD) is a progressive neurodegenerative disorder that primarily affects the dopaminergic A9 nigrostriatal tract. For dopamine neurons specifically, glial cell-derived neurotrophic factor (GDNF) has been shown to promote their survival and proliferation both in culture and in...
| Published: |
|
|---|---|
| Online Access: | http://hdl.handle.net/2047/d20003327 |